FIELD: medicine.
SUBSTANCE: to predict mucosal ulceration of stomach risk level of osmotic stability of erythrocytes (OSE) is evaluated. When OSE in first dilution is equal 17.36±2.36%, second - 38.739±3.6%, third - 69.58±4.30%, fourth- 84.13±2.0%, fifth - 91.88±0.89%, sixth - 99.08±0.55%, seventh - 100±0% high risk of mucosal ulceration is predicted.
EFFECT: method simplifies and extends diagnostic possibilities in determining risk of stomach tissue ulceration.
2 ex, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION OF RISK OF ULCERATION OF TISSUES OF GASTRODUODENAL ZONE BY DETERMINATION OF LIPIDE STRUCTURE OF VENOUS BLOOD | 2006 |
|
RU2337367C1 |
| METHOD OF PRIMARY PREVENTION OF ULCERATIVE DUODENUM DISORDERS AND DEVELOPMENT THEREOF | 2006 |
|
RU2348414C2 |
| METHOD OF OBTAINING MEDICATION, POSSESSING GASTROPROTECTIVE ACTIVITY | 2010 |
|
RU2432957C2 |
| N-ISOVALEOYL-L-GLUMATYL-L-TRYPTOPHAN AS ANTIULCERATIVE AGENT FOR STOMACH AND DUODENUM | 2010 |
|
RU2436587C1 |
| DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
| MEDICAL TEA WITH ANTIULCER ACTIVITY | 2004 |
|
RU2281114C2 |
| TOOL THAT HAS THE ABILITY TO STIMULATE REPARATIVE PROCESSES OF PERIODONTAL TISSUES, AS WELL AS AN ANTIOXIDANT AND ANTI-INFLAMMATORY EFFECT, WHICH IS A 2-ETHYL-6-METHYL-3-HYDROXYPYRIDIA-2- (3-BENZOILPHENIL)-PROPANOATE, AND A PHARMACEUTICAL COMPOSITION BASED ON IT | 2022 |
|
RU2793537C1 |
| METHYL ETHER (± ) 7-[2β-[1-AMINO-3-OXO-4-ACETOXI-(1E)-BUTENYL]-5-OXOCYCLOPENTYL-1a]HETANOIC ACID POSSESSING ANTIULCEROUS ACTIVITY | 1983 |
|
SU1221871A1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF CHEMOPREVENTIVE ACTIVITY OF RESVERATROL IN EXPERIMENTAL CARCINOGENESIS OF LIVER CANCER | 2020 |
|
RU2736238C1 |
| COMPOSITION EXHIBITING ANTIULCER EFFECT | 1995 |
|
RU2116792C1 |
